Nuclear receptor hepatocyte nuclear factor 4α1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter

Molecular Endocrinology

Volumn 22, Issue 1, 2008, Pages 78-90

  Hwang Verslues, Wendy W ^a   Sladek, Frances M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C3; CYCLIN DEPENDENT KINASE INHIBITOR; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

APOC3 GENE; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; LIVER; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PANCREAS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; TUMOR GROWTH;

ADENOVIRIDAE; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; IMMUNOPRECIPITATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 38049077461     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0298     Document Type: Article

References (77)

1. Weinberg WC, Denning MF 2002 P21Waf1 control of epithelial cell cycle and cell fate. Crit Rev Oral Biol Med 13:453-464
2. Drdova B, Vachtenheim J 2005 A role for p21 (WAF1) in the cAMP-dependent differentiation of F9 teratocarcinoma cells into parietal endoderm. Exp Cell Res 304:293-304
3. Savickiene J, Treigyte G, Pivoriunas A, Navakauskiene R, Magnusson KE 2004 Sp1 and NF-κB transcription factor activity in the regulation of the p21 and FasL promoters during promyelocytic leukemia cell monocytic differentiation and its associated apoptosis. Ann NY Acad Sci 1030:569-577
4. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB 1995 Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021
5. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB 1994 Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397-3406
6. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM, Dotto GP 1995 Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 92:5451-5455
7. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ 1995 p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267:1024-1027
8. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, el-Houseini ME 1994 Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389-3396
9. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travali S, Deisseroth AB, Mercer WE 1995 p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/ macrophage differentiation. Cancer Res 55:668-674
10. (WAF1/CIP1) gene. Exp Cell Res 246:280-289
11. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B 1993 WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825
12. WAF1/CIP1 gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271:31723-31728
13. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP 1996 Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142-153
14. Lu S, Liu M, Epner DE, Tsai SY, Tsai MJ 1999 Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter. Mol Endocrinol 13:376-384
15. Saramaki A, Banwell CM, Campbell MJ, Carlberg C 2006 Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 34:543-554
16. Gartel AL, Radhakrishnan SK 2005 Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 65:3980-3985
17. WAF1/CIP1 promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci USA 98:4510-4515
18. CIP1/WAF1 gene expression and inhibition of cell proliferation by overexpression of hepatocyte nuclear factor-4α. Exp Cell Res 302:11-21
19. Naiki T, Nagaki M, Shidoji Y, Kojima H, Imose M, Kato T, Ohishi N, Yagi K, Moriwaki H 2002 Analysis of gene expression profile induced by hepatocyte nuclear factor 4α in hepatoma cells using an oligonucleotide microarray. J Biol Chem 277:14011-14019
20. Sladek FM, Seidel SD 2001 Hepatocyte nuclear factor 4α. London: Academic Press
21. Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, Sladek FM, Duncan SA 2006 Hepatocyte nuclear factor 4α orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci USA 103:8419-8424
22. Garrison WD, Battle MA, Yang C, Kaestner KH, Sladek FM, Duncan SA 2006 Hepatocyte nuclear factor 4α is essential for embryonic development of the mouse colon. Gastroenterology 130:1207-1220
23. Stegmann A, Hansen M, Wang Y, Larsen JB, Lund LR, Ritie L, Nicholson JK, Quistorff B, Simon-Assmann P, Troelsen JT, Olsen J 2006 Metabolome, transcriptome, and bioinformatic cis-element analyses point to HNF-4 as a central regulator of gene expression during enterocyte differentiation. Physiol Genomics 27:141-155
24. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI, Young RA 2004 Control of pancreas and liver gene expression by HNF transcription factors. Science 303:1378-1381
25. Odom DT, Dowell RD, Jacobsen ES, Nekludova L, Rolfe PA, Danford TW, Gifford DK, Fraenkel E, Bell GI, Young RA 2006 Core transcriptional regulatory circuitry in human hepatocytes. Mol Syst Biol 2:2006.0017
26. Kyrmizi I, Hatzis P, Katrakili N, Tronche F, Gonzalez FJ, Talianidis I 2006 Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev 20:2293-2305
27. Ryffel GU 2001 Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J Mol Endocrinol 27:11-29
28. Kalkuhl A, Kaestner K, Buchmann A, Schwarz M 1996 Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours. Carcinogenesis 17: 609-612
29. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, Fleishman DI, Engelhardt NV, Duncan SA 2004 Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology 39: 1038-1047
30. Erdmann S, Senkel S, Arndt T, Lucas B, Lausen J, Klein-Hitpass L, Ryffel GU, Thomas H 2007 Tissue-specific transcription factor HNF4α inhibits cell proliferation and induces apoptosis in the pancreatic INS-1 β-cell line. Biol Chem 388:91-106
31. Lucas B, Grigo K, Erdmann S, Lausen J, Klein-Hitpass L, Ryffel GU 2005 HNF4α reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma. Oncogene 24:6418-6431
32. Spath GF, Weiss MC 1998 Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J Cell Biol 140:935-946
33. Amati B, Alevizopoulos K, Vlach J 1998 Myc and the cell cycle. Front Biosci 3:d250-d268
34. Eilers M, Schirm S, Bishop JM 1991 The MYC protein activates transcription of the α-prothymosin gene. EMBO J 10:133-141
35. Penn LJ, Laufer EM, Land H 1990 C-MYC: evidence for multiple regulatory functions. Semin Cancer Biol 1:69-80
36. Coppola JA, Cole MD 1986 Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature 320:760-763
37. Miner JH, Wold BJ 1991 c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation. Mol Cell Biol 11:2842-2851
38. Ryan KM, Birnie GD 1996 Myc oncogenes: the enigmatic family. Biochem J 314(Pt 3):713-721
39. Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, Brinster RL 1989 Oncogene-induced liver neoplasia in transgenic mice. Oncogene 4:715-724
40. Murakami H, Sanderson ND, Nagy P, Marino PA, Merlino G, Thorgeirsson SS 1993 Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor α in hepatic oncogenesis. Cancer Res 53:1719-1723
41. Wu Y, Renard CA, Apiou F, Huerre M, Tiollais P, Dutrillaux B, Buendia MA 2002 Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors. Oncogene 21:1518-1526
42. Simile MM, De Miglio MR, Muroni MR, Frau M, Asara G, Serra S, Muntoni MD, Seddaiu MA, Daino L, Feo F, Pascale RM 2004 Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis 25:333-341
43. Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, Bachmann MH, Borowsky AD, Ruebner B, Cardiff RD, Yang Q, Bishop JM, Contag CH, Felsher DW 2004 MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431:1112-1117
44. Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H 1993 Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72:233-245
45. Blackwood EM, Eisenman RN 1991 Max: a helix-loophelix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251:1211-1217
46. Solomon DL, Amati B, Land H 1993 Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. Nucleic Acids Res 21:5372-5376
47. Philipp A, Schneider A, Vasrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M 1994 Repression of cyclin D1: a novel function of MYC. Mol Cell Biol 14:4032-4043
48. WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. Cell Growth Differ 10:223-230
49. Claassen GF, Hann SR 2000 A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor β-induced cell-cycle arrest. Proc Natl Acad Sci USA 97:9498-9503
50. WAF1/CIP1 expression through down-regulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells. Biochem Biophys Res Commun 324:860-867
51. WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells. J Biol Chem 280:17617-17625
52. Grand RJ, Grant ML, Gallimore PH 1994 Enhanced expression of p53 in human cells infected with mutant adenoviruses. Virology 203:229-240
53. Hall AR, Dix BR, O'Carroll SJ, Braithwaite AW 1998 p53-dependent cell death/apoptosis is required for a productive adenovirus infection. Nat Med 4:1068-1072
54. Kardassis D, Falvey E, Tsantili P, Hadzopoulou-Cladaras M, Zannis V 2002 Direct physical interactions between HNF-4 and Sp1 mediate synergistic transactivation of the apolipoprotein CIII promoter. Biochemistry 41: 1217-1228
55. Magenheim J, Hertz R, Berman I, Nousbeck J, Bar-Tana J 2005 Negative autoregulation of HNF-4α gene expression by HNF-4α1. Biochem J 388:325-332
56. Takahashi S, Matsuura N, Kurokawa T, Takahashi Y, Miura T 2002 Co-operation of the transcription factor hepatocyte nuclear factor-4 with Sp1 or Sp3 leads to transcriptional activation of the human haem oxygenase-1 gene promoter in a hepatoma cell line. Biochem J 367:641-652
57. Sun K, Montana V, Chellappa K, Brelivet Y, Moras D, Maeda Y, Parpura V, Paschal BM, Sladek FM 2007 Phosphorylation of a conserved serine in the DNA binding domain of nuclear receptors alters intracellular localization. Mol Endocrinol 21:1297-1311
58. Hong YH, Varanasi US, Yang W, Leff T 2003 AMP-activated protein kinase regulates HNF4α transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem 278:27495-27501
59. Claassen GF, Hann SR 1999 Myc-mediated transformation: the repression connection. Oncogene 18:2925-2933
60. Oster SK, Ho CS, Soucie EL, Penn LZ 2002 The myc oncogene: MarvelouslY Complex. Adv Cancer Res 84:81-154
61. Sladek FM, Zhong WM, Lai E, Darnell JE, Jr 1990 Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 4:2353-2365
62. Lavrentiadou SN, Hadzopoulou-Cladaras M, Kardassis D, Zannis VI 1999 Binding specificity and modulation of the human ApoCIII promoter activity by heterodimers of ligand-dependent nuclear receptors. Biochemistry 38:964-975
63. Talianidis I, Tambakaki A, Toursounova J, Zannis VI 1995 Complex interactions between SP1 bound to multiple distal regulatory sites and HNF-4 bound to the proximal promoter lead to transcriptional activation of liver-specific human APOCIII gene. Biochemistry 34:10298-10309
64. Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B 2003 A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci USA 100:8164-8169
65. Gupta RK, Gao N, Gorski RK, White P, Hardy OT, Rafiq K, Brestelli JE, Chen G, Stoeckert CJ, Jr., Kaestner KH 2007 Expansion of adult β-cell mass in response to increased metabolic demand is dependent on HNF-4α. Genes Dev 21:756-769
66. Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A, Amati B 2003 Genomic targets of the human c-Myc protein. Genes Dev 17:1115-1129
67. Yang C, Bolotin E, Jiang T, Sladek FM, Martinez E 2007 Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene 389:52-65
68. Zeller KI, Jegga AG, Aronow BJ, O'Donnell KA, Dang CV 2003 An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol 4:R69
69. Lu S, Jenster G, Epner DE 2000 Androgen induction of cyclin-dependent kinase inhibitor p21 gene: role of androgen receptor and transcription factor Sp1 complex. Mol Endocrinol 14:753-760
70. Jiang G, Sladek FM 1997 The DNA binding domain of hepatocyte nuclear factor 4 mediates cooperative, specific binding to DNA and heterodimerization with the retinoid X receptor α. J Biol Chem 272:1218-1225
71. Maeda Y, Seidel SD, Wei G, Liu X, Sladek FM 2002 Repression of hepatocyte nuclear factor 4α tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity. Mol Endocrinol 16:402-410
72. Datto MB, Yu Y, Wang XF 1995 Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem 270:28623-28628
73. Ruse Jr MD, Privalsky ML, Sladek FM 2002 Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4α1: modulation by the F domain. Mol Cell Biol 22:1626-1638
74. Jiang G, Nepomuceno L, Hopkins K, Sladek FM 1995 Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol Cell Biol 15:5131-5143
75. Maeda Y, Rachez C, Hawel 3rd L, Byus CV, Freedman LP, Sladek FM 2002 Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205. Mol Endocrinol 16:1502-1510
76. Spath GF, Weiss MC 1997 Hepatocyte nuclear factor 4 expression overcomes repression of the hepatic phenotype in dedifferentiated hepatoma cells. Mol Cell Biol 17:1913-1922
77. Maeda Y, Hwang-Verslues WW, Wei G, Fukazawa T, Durbin ML, Owen LB, Liu X, Sladek FM 2006 Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4α (HNF4α) gene. Biochem J 400:303-313